CUAMC
OVID icon

China Universal Asset Management Company’s Ovid Therapeutics OVID Stock Holding History

China Universal Asset Management Company’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,650
Closed -$16.1K – 516
2024
Q3 		$16.1K Buy
13,650
+5,315
+64% +$5.55K ﹤0.01% 411
2024
Q2 		$6.41K Sell
8,335
-5,244
-39% -$14.6K ﹤0.01% 405
2024
Q1 		$41.4K Buy
13,579
+5,401
+66% +$18.1K 0.01% 418
2023
Q4 		$26.3K Buy
+8,178
New +$28K 0.01% 406
2022
Q4 		– Sell
-660
Closed -$1K – 439
2022
Q3 		$1K Buy
+660
New +$1.38K ﹤0.01% 406

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

China Universal Asset Management Company's OVID Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Ovid Therapeutics (OVID) in Q4 2024, closing a stake of 13,650 shares — an estimated $16.1K sold.

China Universal Asset Management Company first reported a position in OVID in Q3 2022 and held it in 5 quarters. The position peaked at $41.4K in Q1 2024. 82 funds tracked by Wall St. Rank hold OVID as of Q4 2024.

  • China Universal Asset Management Company reported no remaining Ovid Therapeutics position as of Q4 2024 after selling out during the quarter.
  • China Universal Asset Management Company sold 13,650 Ovid Therapeutics shares in Q4 2024, an estimated $16.1K.
  • China Universal Asset Management Company first reported a position in Ovid Therapeutics in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Ovid Therapeutics position peaked at $41.4K in Q1 2024.
  • 82 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.